Luigi Grasso
Gründer bei Navrogen, Inc.
Aktive Positionen von Luigi Grasso
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Navrogen, Inc.
 Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.01.2017 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | - | |
| Gründer | 01.01.2017 | - |
Karriereverlauf von Luigi Grasso
Ehemalige bekannte Positionen von Luigi Grasso
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2000 | 01.04.2018 |
| Gründer | 23.02.2011 | 01.04.2018 |
Ausbildung von Luigi Grasso
| University of Catania | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Italien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Börse
- Insiders
- Luigi Grasso
- Erfahrung
